Sign in to continue:

Monday, March 9th, 2026

Prudential plc Share Buyback and Issued Shares Update for March 2026 – Hong Kong Exchange Disclosure




Prudential plc – Share Repurchase Disclosure (March 2026)

Prudential plc Discloses Recent Share Repurchases and Cancellations

Key Developments Investors Should Know (March 2026)

Prudential plc, a leading international financial services group, has made a significant disclosure regarding changes in its share capital due to recent share repurchase activities. The details, as required under Hong Kong Stock Exchange rules, are potentially price-sensitive and relevant for shareholders and market participants.

Summary of Share Repurchases and Cancellations

  • Repurchase and Cancellation: On 4 March 2026, Prudential plc repurchased 364,056 ordinary shares, which were subsequently cancelled on 6 March 2026. This represents approximately 0.0144% of the company’s issued shares prior to the event.
  • Share Price Paid: The volume-weighted average price for these repurchased shares was GBP 10.872 per share.
  • Outstanding Repurchases Pending Cancellation: As of 6 March 2026, there were two further tranches of shares repurchased but not yet cancelled:
    • 357,726 shares on 5 March 2026 at an average price of GBP 11.0407 per share.
    • 371,760 shares on 6 March 2026 at an average price of GBP 10.7364 per share.
  • Closing Share Count: After these cancellations, the number of issued shares (excluding treasury shares) was 2,533,980,628.

Details of the Latest Repurchase

  • On 6 March 2026, Prudential repurchased 371,760 ordinary shares on the London Stock Exchange (not on the Hong Kong Exchange).
  • The repurchase price ranged from GBP 10.555 to GBP 11.005 per share, with a total consideration of GBP 3,991,363.71.
  • All repurchased shares are intended for cancellation, not for holding as treasury shares.

Shareholder Mandate and Limits

  • The current repurchase program is operating under a shareholder mandate granted on 14 May 2025, authorizing the company to repurchase up to 262,668,701 shares.
  • To date, a total of 73,190,351 shares have been repurchased under this mandate, equivalent to approximately 2.81% of the issued shares at the time of the mandate.
  • There is a moratorium on new share issues, sales, or transfers of treasury shares until 5 April 2026, following these repurchases, as per the rules.

Implications for Shareholders and Share Price

These ongoing share repurchases and cancellations are important for shareholders because they:

  • Directly reduce the total number of shares in issue, which can enhance earnings per share (EPS) and potentially support the share price.
  • Demonstrate that the company is using its capital to return value to shareholders, which may be interpreted as a sign of confidence in the company’s financial position and future prospects.
  • The moratorium on new share issues or treasury share sales may reinforce market confidence in the buyback’s impact by preventing dilution in the near term.

Additionally, the repurchase prices provide a reference point for the company’s perceived valuation by its own management, which can be a signal for market participants.

Other Noteworthy Points

  • No sale of treasury shares was reported during this period.
  • All transactions on other exchanges were conducted in accordance with relevant domestic rules (in this case, the London Stock Exchange).

Conclusion

The share repurchase program and associated cancellations are significant, price-sensitive events. They reflect the company’s active approach to capital management, which may influence investor sentiment and the share price in the short to medium term.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult a professional advisor before making investment decisions. The information is based on official disclosures as of March 2026 and may be subject to further updates or changes.




View Prudential USD Historical chart here



AJJ Medtech Appoints William Ong as CEO of AJJ Healthcare to Drive AI-Driven Innovation and Growth in Singapore’s Healthcare Sector 1

AJJ Medtech Appoints Healthcare Veteran William Ong as CEO of Subsidiary – Signals Strategic Expansion into AI, Robotics, and ESG AJJ Medtech Appoints Healthcare Veteran William Ong as CEO of Subsidiary – Signals Strategic...

SDAI Limited Takes Legal Action Following Special Audit Findings and Plans to Report to Authorities

SDAI Limited Announces Immediate Remedial Actions Following Special Audit Report and Receipt of Legal Advice SDAI Limited Announces Immediate Remedial Actions Following Special Audit Report and Receipt of Legal Advice Key Announcement Highlights Receipt...

Daiwa House Logistics Trust 3Q FY2025 Business Update: Portfolio Performance, Financials & Market Outlook

Daiwa House Logistics Trust 3Q FY2025: Detailed Investor Update Daiwa House Logistics Trust Reports 3Q FY2025 Business Update: Key Details for Investors Summary of Key Financial and Operational Highlights Portfolio Occupancy: 92.0% as at...

   Ad